KNSA
Kiniksa Pharmaceuticals Ltd
75.20$
+0.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -1,772.2% | -327.7% | 2.6% | 4.9% | 6.1% | 3.8% | |
| – | – | – | – | 31.2% | 6.1% | 1.1% | 0.9% | 0.4% | 0.3% | |
| – | – | – | – | 271.0% | 65.3% | 11.4% | 10.0% | 7.3% | 4.5% | |
| – | – | – | – | 327.6% | 65.6% | -72.8% | – | – | – | |
| – | – | – | – | -56.0% | 1.8% | -10.3% | 0.5% | 5.9% | 7.6% | |
| – | – | – | – | 3.7% | 53.0% | 0.0% | 0.0% | 0.1% | 0.0% | |
| – | – | – | – | -304.3% | 333.7% | -3.7% | -10.9% | 8.9% | 5.6% | |
| – | – | – | – | 85.1% | 15.3% | -0.4% | -0.8% | -1.2% | -1.1% | |
| – | – | – | – | 2,947.6% | 15.3% | 1.1% | 0.6% | 2.9% | 1.8% | |
| – | – | – | – | 871.1% | 21.3% | 0.1% | -5.5% | 17.9% | 11.2% | |
| – | – | – | – | -1,775.9% | -380.6% | 2.6% | 4.9% | 6.0% | 3.8% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.